## **Core Concept**
Sanfilippo syndromes, also known as Mucopolysaccharidosis type III (MPS III), are a group of genetic disorders caused by the deficiency of enzymes needed to break down and recycle sugar molecules called glycosaminoglycans (GAGs), specifically **heparan sulfate** and **dermatan sulfate**. These disorders are characterized by the accumulation of these GAGs within cells, leading to cellular dysfunction.

## **Why the Correct Answer is Right**
The Sanfilippo syndromes are associated with the accumulation of **heparan sulfate**, a type of glycosaminoglycan. This accumulation occurs due to deficiencies in one of five enzymes (A, B, C, D, or E) required for the breakdown of heparan sulfate. The correct answer, **heparan sulfate**, directly relates to the pathophysiology of Sanfilippo syndromes, as the disorders are primarily caused by the inability to properly degrade this GAG.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **hyaluronic acid** is a type of GAG, it is not specifically implicated in the pathogenesis of Sanfilippo syndromes.
- **Option B:** **Keratan sulfate** is another type of GAG, but it is not the primary GAG affected in Sanfilippo syndromes.
- **Option D:** **Chondroitin sulfate** is also a GAG, but like hyaluronic acid and keratan sulfate, it is not the specific GAG associated with Sanfilippo syndromes.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Sanfilippo syndromes is that they are characterized by **severe neurological symptoms**, including intellectual disability, behavioral problems, and loss of motor skills, due to the accumulation of heparan sulfate in the brain. Early diagnosis and supportive care are crucial in managing the condition.

## **Correct Answer:** .